Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure

Clinical Biochemistry

Volumn 40, Issue 5-6, 2007, Pages 326-329

  Kavsak, Peter A ^a   MacRae, Andrew R ^b   Newman, Alice M ^c   Lustig, Viliam ^b   Palomaki, Glenn E ^d   Ko, Dennis T ^c   Tu, Jack V ^c   Jaffe, Allan S ^e  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d WOMEN AND INFANTS HOSPITAL   (United States)

^e MAYO CLINIC   (United States)

Author keywords

Acute myocardial infarction; C reactive protein; Congestive heart failure; Death; Emergency department

Indexed keywords

C REACTIVE PROTEIN; TROPONIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONCENTRATION (PARAMETERS); CONGESTIVE HEART FAILURE; EMERGENCY WARD; FEMALE; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; STATISTICAL ANALYSIS; THORAX PAIN;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE;

EID: 33847233869     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.10.025     Document Type: Article

References (21)

1. Yu H., and Rifai N. High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy. Clin. Biochem. 33 (2000) 601-610
2. Toss H., Lindahl B., Siegbahn A., and Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation 96 (1997) 4204-4210
3. James S.K., Armstrong P., Barnathan E., et al. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome. J. Am. Coll Cardiol. 41 (2003) 916-924
4. Lindahl B., Toss H., Siegbahn A., Venge P., and Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N. Engl. J. Med. 343 (2000) 1139-1147
5. James S.K., Lindahl B., Siegbahn A., et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease. Circulation 108 (2003) 275-281
6. Suleiman M., Khatib R., Agmon Y., et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction. J. Am. Coll Cardiol. 47 (2006) 962-968
7. Pepys M.B., Hirschfield G.M., Tennent G.A., et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 406 (2006) 1217-1221
8. Griselli M., Herbert J., Hutchinson W.L., et al. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J. Exp. Med. 190 (1999) 1733-1739
9. Buffon A., Biasucci L.M., Liuzzo G., D'Onofrio G., Crea F., and Maseri A. Widespread coronary inflammation in unstable angina. N. Engl. J. Med. 347 (2002) 5-12
10. Kavsak P.A., MacRae A.R., Lustig V., et al. The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. Am. Heart J. 152 (2006) 118-125
11. MacRae A.R., Kavsak P.A., Lustig V., et al. Assessing the requirement for the six-hour interval between specimens in the American Heart Association classification of myocardial infarction in epidemiology and clinical research studies. Clin. Chem. 52 (2006) 2028-2035
12. Kavsak P.A., MacRae A.R., Palomaki G.E., et al. Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of troponin naïve emergency department patients. Clin. Chem. (2006 (Sep 21)) [Electronic publication ahead of print]
13. Venge P., Lindahl B., and Wallentin L. New generation cardiac troponin I assay for the access immunoassay system. Clin. Chem. 47 (2001) 959-961
14. Pai J.K., Pischon T., Ma J., et al. Inflammatory markers and the risk of coronary heart disease in men and women. N. Engl. J. Med. 351 (2004) 2599-2610
15. Nilsson T.K., Boman K., Jansson J., et al. Comparison of soluble thrombomodulin, von Willebrand factor, tPA/PAI-1 complex, and high-sensitvity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (Stabilyte) stored at - 70 °C for 8-11 years. Thromb. Res. 116 (2005) 249-254
16. Kavsak P., Lustig V., and MacRae A.R. Clinical evaluation of the Beckman Coulter AccuTnI assay for the early detection of acute myocardial infarction. Clin Chem. 50 (2004) A5 [abstr]
17. Pearson T.A., Mensah G.A., Alexander W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
18. Austin P.C., Daly P.A., and Tu J.V. A multicentre study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am. Heart J. 144 (2002) 290-296
19. Venge P., Lagerqvist B., Diderholm E., Lindahl B., and Wallentin L. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy). Am. J. Cardiol. 89 (2002) 1035-1041
20. De Servi S., Mariani M., Mariani G., and Mazzone A. C-reactive protein increase in unstable coronary disease cause or effect?. J. Am. Coll. Cardiol. 46 (2005) 1496-1502
21. Ridker P.M., Cannon C.P., Morrow D., et al. C-reactive protein levels and outcomes after statin therapy. N. Engl. J. Med. 353 (2005) 20-28